Literature DB >> 2789348

[Effects of therapy with aminaftone on chronic venous and lymphatic stasis].

D De Anna, F Mari, S Intini, V Gasbarro, A Sortini, E Pozza, R Marzola, U Taddeo, F Bresadola, I Donini.   

Abstract

Following a short introduction on the physiopathology of the phlebo-lymphatic system, the results of a study carried out on 114 patients suffering from chronic venous insufficiency (CVI) treated at the Department of General Clinical Surgery and Surgical Therapy of the University of Ferrara are reported. These patients were subdivided into two random groups and treated with common phlebotonic drugs and aminaftone, respectively. Both groups were also subjected to those physical and medical measures that are usually adopted for the treatment of such patients. The therapeutic effects were assessed by comparing symptomatology before and after 90 days of treatment, both subjectively (patient's assessment of the symptoms by means of a scoring system) and with objective methods (measurements and echo-Doppler examinations). The differences between the two groups were statistically very significant in favour of patients who had taken aminaftone. Excellent results were obtained in the treatment of CVI as well as in lymphatic-related pathology (lymphedema).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2789348

Source DB:  PubMed          Journal:  Minerva Cardioangiol        ISSN: 0026-4725            Impact factor:   1.347


  5 in total

1.  [Drug Treatment of Chronic Venous Diesease].

Authors:  Miloš D Pavlović
Journal:  Wien Med Wochenschr       Date:  2016-07-05

2.  3-Methyl-1,4-dioxo-1,4-dihydro-naphthalen-2-yl 4-amino-benzoate.

Authors:  Massimo Bambagiotti-Alberti; Gianluca Bartolucci; Bruno Bruni; Silvia Coran; Massimo Di Vaira
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-03-14

Review 3.  Phlebotonics for venous insufficiency.

Authors:  Maria José Martinez-Zapata; Robin W M Vernooij; Sonia Maria Uriona Tuma; Airton T Stein; Rosa M Moreno; Emilio Vargas; Dolors Capellà; Xavier Bonfill Cosp
Journal:  Cochrane Database Syst Rev       Date:  2016-04-06

4.  Aminaphtone Efficacy in Primary and Secondary Raynaud's Phenomenon: A Feasibility Study.

Authors:  Barbara Ruaro; Carmen Pizzorni; Sabrina Paolino; Elisa Alessandri; Alberto Sulli
Journal:  Front Pharmacol       Date:  2019-04-04       Impact factor: 5.810

5.  Phlebotonics for venous insufficiency.

Authors:  Maria José Martinez-Zapata; Robin Wm Vernooij; Daniel Simancas-Racines; Sonia Maria Uriona Tuma; Airton T Stein; Rosa Maria M Moreno Carriles; Emilio Vargas; Xavier Bonfill Cosp
Journal:  Cochrane Database Syst Rev       Date:  2020-11-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.